IL89207A0 - Carbamic acid ester of substituted 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepines,their preparation and pharmaceutical compositions containing them - Google Patents

Carbamic acid ester of substituted 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL89207A0
IL89207A0 IL89207A IL8920789A IL89207A0 IL 89207 A0 IL89207 A0 IL 89207A0 IL 89207 A IL89207 A IL 89207A IL 8920789 A IL8920789 A IL 8920789A IL 89207 A0 IL89207 A0 IL 89207A0
Authority
IL
Israel
Prior art keywords
alkyl
halogen
formula
ring
hydroxy
Prior art date
Application number
IL89207A
Other languages
English (en)
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of IL89207A0 publication Critical patent/IL89207A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL89207A 1988-03-01 1989-02-07 Carbamic acid ester of substituted 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepines,their preparation and pharmaceutical compositions containing them IL89207A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK107688A DK107688D0 (da) 1988-03-01 1988-03-01 Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner

Publications (1)

Publication Number Publication Date
IL89207A0 true IL89207A0 (en) 1989-09-10

Family

ID=8100728

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89207A IL89207A0 (en) 1988-03-01 1989-02-07 Carbamic acid ester of substituted 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepines,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US5017571A (de)
EP (1) EP0331130B1 (de)
JP (1) JPH01254679A (de)
KR (1) KR0126473B1 (de)
AT (1) ATE95179T1 (de)
AU (1) AU613716B2 (de)
CA (1) CA1312863C (de)
DE (1) DE68909448T2 (de)
DK (1) DK107688D0 (de)
ES (1) ES2059592T3 (de)
FI (1) FI94955C (de)
IE (1) IE64247B1 (de)
IL (1) IL89207A0 (de)
NO (1) NO173825C (de)
NZ (1) NZ228151A (de)
PH (1) PH26368A (de)
PT (1) PT89887B (de)
ZA (1) ZA891537B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5470850A (en) * 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US20030125317A1 (en) * 1996-10-02 2003-07-03 Smithkline Beecham Corporation Vitronectin receptor antagonists
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US20080009478A1 (en) * 2003-10-22 2008-01-10 Arena Pharmaceuticals, Inc. Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
BRPI0515862A2 (pt) 2004-12-23 2011-10-11 Arena Pharm Inc uso de fentermina e agonista seletivo do receptor de 5ht-2c na preparação de composições, composições moduladoras do receptor de 5ht-2c e forma de dosagem unitária compreendendo as mesmas
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
EP3485878A1 (de) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Darreichungsformen von 5-ht2c-agonisten, die nützlich für gewichtskontrolle sind
CA2886875A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
ZA792044B (en) * 1978-05-08 1980-05-28 Scherico Ltd Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
US4284555A (en) * 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA1312863C (en) 1993-01-19
NZ228151A (en) 1991-08-27
NO173825B (no) 1993-11-01
NO890857D0 (no) 1989-02-28
ZA891537B (en) 1989-11-29
KR0126473B1 (ko) 1997-12-24
NO890857L (no) 1989-09-04
ES2059592T3 (es) 1994-11-16
ATE95179T1 (de) 1993-10-15
JPH01254679A (ja) 1989-10-11
NO173825C (no) 1994-02-09
IE890420L (en) 1989-09-01
US5017571A (en) 1991-05-21
DE68909448T2 (de) 1994-02-10
EP0331130B1 (de) 1993-09-29
AU613716B2 (en) 1991-08-08
KR890014494A (ko) 1989-10-24
DE68909448D1 (de) 1993-11-04
AU3090789A (en) 1989-09-07
PH26368A (en) 1992-06-01
FI94955B (fi) 1995-08-15
FI94955C (fi) 1995-11-27
EP0331130A1 (de) 1989-09-06
DK107688D0 (da) 1988-03-01
FI890841A7 (fi) 1989-09-02
FI890841A0 (fi) 1989-02-22
IE64247B1 (en) 1995-07-26
PT89887A (pt) 1989-11-10
PT89887B (pt) 1994-05-31

Similar Documents

Publication Publication Date Title
NZ228151A (en) Carbamic acid esters of 7-hydroxy-2,3,4,5 tetrahydro-1h- 3-benzazepines and pharmaceutical compositions
ES541709A0 (es) Un procedimiento para la preparacion de derivados de fenoxi-c3-c7-alquiloxi-3,4-dihidro-2h-1-benzopirano
ES2142228A1 (es) Mezclas de esteres de acido polialquilpiperidin-4-il dicarboxilico como estabilizantes para materiales organicos.
AU577772B2 (en) Di-acyloxy naphthalenes & di-hydroxy intermediates as anti-psoriatic agents
NO845147L (no) Fremgangsmaate for fremstilling av forbindelser med anti-psoriasis-aktivitet
DE69021101D1 (de) Imidazochinolon-Derivate.
ES2070522T3 (es) Compuestos anti-inflamatorios.
DE3787844D1 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
FR2709489B1 (fr) Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
HUT51597A (en) Process for production of derivatives of n,n-disubstituated diaryl-alcane-carbonic acid amid and medical compositions containing them as active substances
ATE44745T1 (de) Pyrimido(2,1-b)benzothiazolderivate und ihre salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen.
DK87689A (da) Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
IL95320A0 (en) 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives,their preparation and pharmaceutical compositions containing them
ATE139533T1 (de) Cyclopropachromenderivate
ATE67198T1 (de) 4-(3-cumarinyl)-thiazol-derivate mit antiallergischer, antianaphylaktischer und antiarthritischer wirkung und diese derivate enthaltende zusammensetzungen.
DE69124392D1 (de) Tri(c1-c6 alkoxy)benzolderivat
DE69206447D1 (de) 8-Chloro-benzothiazepin-Verbindung zur Prophylaxe und Behandlung der Folgen der zerebralen Nekrose von Neurozyten.
CS864885A2 (en) Herbicidni prostredek a zpusob vyroby jeho ucinne latky

Legal Events

Date Code Title Description
RH Patent void